Oryzon Genomics S.A. (BME:ORY)
2.920
+0.106 (3.77%)
May 18, 2026, 4:14 PM CET
Oryzon Genomics Employees
Oryzon Genomics had 46 employees as of December 31, 2025. The number of employees decreased by 1 or -2.13% compared to the previous year.
Employees
46
Change (1Y)
-1
Growth (1Y)
-2.13%
Revenue / Employee
€237,705
Profits / Employee
€48,571
Market Cap
218.12M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 46 | -1 | -2.13% |
| Dec 31, 2024 | 47 | 1 | 2.17% |
| Dec 31, 2023 | 46 | 2 | 4.78% |
| Dec 31, 2022 | 44 | 0 | - |
| Dec 31, 2021 | 44 | 1 | 1.15% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Grifols | 25,000 |
| Almirall | 2,108 |
| Laboratorios Farmaceuticos Rovi | 2,045 |
| Clínica Baviera | 1,910 |
| Laboratorio Reig Jofre | 1,512 |
| Prim, S.A. | 984 |
| Atrys Health | 758 |
| Pharma Mar | 505 |
Oryzon Genomics News
- 3 days ago - ORYZON Reports Financial Results and Corporate Update for Quarter Ended March 31st, 2026 - GlobeNewsWire
- 5 days ago - ORYZON to Present Updated Positive Clinical Data for Iadademstat in Acute Myeloid Leukemia at EHA 2026 - GlobeNewsWire
- 2 months ago - Oryzon Genomics announces patent grant decision in Mexico - TheFly
- 2 months ago - ORYZON Reports Financial Results and Corporate Update for Quarter Ended December 31st, 2025 - GlobeNewsWire
- 2 months ago - Oryzon Genomics receives EMA approval for Phase II study of iadademstat - TheFly
- 3 months ago - Oryzon Genomics appoints Rolando Gutierrez-Esteinou as CMO, CNS Programs - TheFly
- 3 months ago - Oryzon Genomics management to meet with Maxim - TheFly
- 3 months ago - Oryzon Genomics announces first patient dosed in Phase Ib iadademstat study - TheFly